Studies have shown that STAT3 phosphorylation by IL-6 suppresses RFX1 expression in CD4+ T cells in patients with SLE, and the pSTAT3 level was high in CD4+ T cells among SLE cases (Zhao et al., 2018). This evidence concerns the gene CD4 and systemic lupus erythematosus.